Showing results (1211-1220 of 4,702) with videos related to
Sort By:
Pageof 471
Seminars in Oncology|December 1, 1986
Alpha-interferon in the treatment of nodular lymphomasW J Urba, D L LongoSeminars in Oncology|February 7, 2022
Pathogenic signaling in multiple myelomaArnold Bolomsky, Ryan M YoungSeminars in Oncology|February 22, 2022
Modern radiographic imaging in multiple myeloma, what is the minimum requirement?Esther Mena, Evrim B Turkbey, Liza LindenbergSeminars in Oncology|April 13, 2022
Novel targeted therapies for advanced non-small lung cancerOmar Abughanimeh, Anahat Kaur, Badi El Osta, et al.Seminars in Oncology|July 26, 2022
Military exposures and lung cancer in United States VeteransWilliam Grier, Hatoon Abbas, Rediet Regassa Gebeyehu, et al.Seminars in Oncology|July 13, 2022
Loss of function STK11 alterations and poor outcomes in non-small-cell lung cancer: Literature and case series of US VeteransHafsa Farooq, Harold Bien, Victor Chang, et al.Seminars in Oncology|July 13, 2022
Lung cancer screening at the VA: Past, present and futureNicholas M Maurice, Nichole T TannerSeminars in Oncology|April 10, 2022
Evidence- and consensus-based guidelines for drug-drug interactions with anticancer drugs; A practical and universal tool for managementRoelof W F van Leeuwen, Marianne le Comte, Anna K L Reyners, et al.Seminars in Oncology|June 1, 1985
In vivo studies on high-dose 1-beta-D-arabinofuranosylcytosine (HDara-C) and 1-beta-D-arabinofuranosyluracil (ara-U) with respect to pharmacokinetics, cell kinetics, and cytotoxicity in a rat myelocytic leukemia model (BNML)L P Colly, R Willemze, W Honders, et al.Pageof 471